1
|
Kubo T, Sunami K, Koyama T, Kitami M, Fujiwara Y, Kondo S, Yonemori K, Noguchi E, Morizane C, Goto Y, Maejima A, Iwasa S, Hamaguchi T, Kawai A, Namikawa K, Arakawa A, Sugiyama M, Ohno M, Yoshida T, Hiraoka N, Yoshida A, Yoshida M, Nishino T, Furukawa E, Narushima D, Nagai M, Kato M, Ichikawa H, Fujiwara Y, Kohno T, Yamamoto N. The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology. ESMO Open 2024; 9:102981. [PMID: 38613908 PMCID: PMC11033064 DOI: 10.1016/j.esmoop.2024.102981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2023] [Revised: 03/04/2024] [Accepted: 03/04/2024] [Indexed: 04/15/2024] Open
Abstract
BACKGROUND Comprehensive genome profiling (CGP) serves as a guide for suitable genomically matched therapies for patients with cancer. However, little is known about the impact of the timing and types of cancer on the therapeutic benefit of CGP. MATERIALS AND METHODS A single hospital-based pan-cancer prospective study (TOP-GEAR; UMIN000011141) was conducted to examine the benefit of CGP with respect to the timing and types of cancer. Patients with advanced solid tumors (>30 types) who either progressed with or without standard treatments were genotyped using a single CGP test. The subjects were followed up for a median duration of 590 days to examine therapeutic response, using progression-free survival (PFS), PFS ratio, and factors associated with therapeutic response. RESULTS Among the 507 patients, 62 (12.2%) received matched therapies with an overall response rate (ORR) of 32.3%. The PFS ratios (≥1.3) were observed in 46.3% (19/41) of the evaluated patients. The proportion of subjects receiving such therapies in the rare cancer cohort was lower than that in the non-rare cancer cohort (9.6% and 17.4%, respectively; P = 0.010). However, ORR of the rare cancer patients was higher than that in the non-rare cancer cohort (43.8% and 20.0%, respectively; P = 0.046). Moreover, ORR of matched therapies in the first or second line after receiving the CGP test was higher than that in the third or later lines (62.5% and 21.7%, respectively; P = 0.003). Rare cancer and early-line treatment were significantly and independently associated with ORR of matched therapies in multivariable analysis (P = 0.017 and 0.004, respectively). CONCLUSION Patients with rare cancer preferentially benefited from tumor mutation profiling by increasing the chances of therapeutic response to matched therapies. Early-line treatments after profiling increase the therapeutic benefit, irrespective of tumor types.
Collapse
Affiliation(s)
- T Kubo
- Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo
| | - K Sunami
- Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo; Division of Genome Biology, National Cancer Center Research Institute, Tokyo
| | - T Koyama
- Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo
| | - M Kitami
- Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo
| | - Y Fujiwara
- Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo; Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi
| | - S Kondo
- Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo
| | - K Yonemori
- Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo; Department of Medical Oncology, National Cancer Center Hospital, Tokyo
| | - E Noguchi
- Department of Medical Oncology, National Cancer Center Hospital, Tokyo
| | - C Morizane
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo
| | - Y Goto
- Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo
| | - A Maejima
- Department of Medical Oncology, National Cancer Center Hospital, Tokyo; Department of Urology, National Cancer Center Hospital, Tokyo
| | - S Iwasa
- Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo
| | - T Hamaguchi
- Department of Medical Oncology, Saitama Medical University International Medical Center, Saitama
| | - A Kawai
- Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo
| | - K Namikawa
- Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo
| | - A Arakawa
- Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo
| | - M Sugiyama
- Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo
| | - M Ohno
- Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo
| | - T Yoshida
- Department of Genetic Services and Medicine, National Cancer Center Hospital, Tokyo
| | - N Hiraoka
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo
| | - A Yoshida
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo
| | - M Yoshida
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo
| | - T Nishino
- Department of Laboratory Medicine, National Cancer Center Hospital, Tokyo
| | - E Furukawa
- Division of Bioinformatics, National Cancer Center Research Institute, Tokyo
| | - D Narushima
- Division of Bioinformatics, National Cancer Center Research Institute, Tokyo
| | - M Nagai
- Division of Bioinformatics, National Cancer Center Research Institute, Tokyo
| | - M Kato
- Division of Bioinformatics, National Cancer Center Research Institute, Tokyo
| | - H Ichikawa
- Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo; Division of Translational Genomics, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, Tokyo, Japan
| | - Y Fujiwara
- Department of Medical Oncology, National Cancer Center Hospital, Tokyo
| | - T Kohno
- Division of Genome Biology, National Cancer Center Research Institute, Tokyo; Division of Translational Genomics, National Cancer Center Exploratory Oncology Research & Clinical Trial Center, Tokyo, Japan
| | - N Yamamoto
- Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo.
| |
Collapse
|
2
|
Koyama T, Nishikawa J, Yaguchi K, Irino T, Rikukawa A. A comparison of the physical demands generated by playing different opponents in basketball friendly matches. Biol Sport 2024; 41:253-260. [PMID: 38188115 PMCID: PMC10765436 DOI: 10.5114/biolsport.2024.129474] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Revised: 02/21/2023] [Accepted: 05/22/2023] [Indexed: 01/09/2024] Open
Abstract
This study aimed to compare the physical demands of playing opponents of different skill levels in basketball. Eighteen men's college basketball players wore accelerometers to measure the relative accumulated acceleration load (AAL), estimated equivalent distance, and frequencies of sprint, jump, and exertion events during games against professional teams (Pro), teams at the same competition level (Collegiate), and teams comprising intra-team members in practice games (Scrimmage). Internal responses were calculated using the relative rating of perceived exertion (sRPE). A repeated measures analysis of variance, Bonferroni post-hoc tests, and standardized Cohen's effect sizes were calculated to compare the physical demands and internal responses across matches played against different levels of opponents. The results showed that in the game against the Pro, AAL (arbitrary units), sprint events (cases per min), and exertion events (cases per min) were significantly (p < .05) higher than those in games against the Collegiate and Scrimmage teams. As the competitive level of the opponents increased, the relative external load of the participants also increased. Conversely, internal responses measured using sRPE were lower after games against the Pro than those against the Collegiate. Internal and external loads may vary from each other depending on contextual factors.
Collapse
Affiliation(s)
- Takeshi Koyama
- Department of Physical Education, Tokai university, Japan
| | - Jun Nishikawa
- Graduate School of Physical Education, Tokai university, Japan
| | - Kaishi Yaguchi
- Graduate School of Physical Education, Tokai university, Japan
| | - Takayuki Irino
- Department of Sports Promotion Center, Tokai university, Japan
| | - Akira Rikukawa
- Department of Sports Promotion Center, Tokai university, Japan
| |
Collapse
|
3
|
Koyama T, Tanigawa T, Sugimoto M, Osaka I. A retrospective study on the effects of dry period length on milk yield and postpartum health in Holstein dairy cows. Anim Sci J 2024; 95:e13912. [PMID: 38302096 DOI: 10.1111/asj.13912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2023] [Revised: 12/04/2023] [Accepted: 12/25/2023] [Indexed: 02/03/2024]
Abstract
We retrospectively analyzed the effects of dry period length (DPL) on milk yield and postpartum health using 152 commercial dairy farm data, including 46,228 dairy cows in Hokkaido, Japan, and examined the optimal DPL. The DPL was divided into eight categories: ≤25, 26-35, 36-45, 46-55, 56-65 (reference), 66-75, 76-85, and ≥86 d. The total milk yields (the sum of milk yield during the 55 d before and the 305 d milk yield after calving) of cows with DPL of ≤55 d did not differ from the reference group. Cows with DPL of ≤55 d had lower odds ratios (OR) of a displaced abomasum (DA), ketosis, milk fever (MF), and abnormal milk fat-to-protein ratio but had higher puerperal fever (PF) and stillbirth ORs than the reference group. Cows with a DPL of 46-55 d had the lowest PF and stillbirth ORs among the short DPL categories. The extremely short (≤25 d) and long (≥86 d) DPL increased the ORs of mastitis and abnormal liner score of somatic cell counts (SCCs) compared with the reference group. We conclude that shortening DPL can reduce postpartum health problems without reducing milk yield and that the optimal DPL is 46-55 d.
Collapse
Affiliation(s)
- Takeshi Koyama
- Hokkaido Research Organization, Animal Research Center, Shintoku, Hokkaido, Japan
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, Japan
| | - Tamako Tanigawa
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, Japan
| | - Masahito Sugimoto
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, Japan
| | - Ikuo Osaka
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, Japan
- LTD Research & Development Div, Mito Research Farm, Meiji Feed CO., Mito, Japan
| |
Collapse
|
4
|
Loong HH, Shimizu T, Prawira A, Tan AC, Tran B, Day D, Tan DSP, Ting FIL, Chiu JW, Hui M, Wilson MK, Prasongsook N, Koyama T, Reungwetwattana T, Tan TJ, Heong V, Voon PJ, Park S, Tan IB, Chan SL, Tan DSW. Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group. ESMO Open 2023; 8:101586. [PMID: 37356359 PMCID: PMC10319859 DOI: 10.1016/j.esmoop.2023.101586] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2022] [Revised: 03/27/2023] [Accepted: 05/18/2023] [Indexed: 06/27/2023] Open
Abstract
INTRODUCTION Next-generation sequencing (NGS) diagnostics have shown clinical utility in predicting survival benefits in patients with certain cancer types who are undergoing targeted drug therapies. Currently, there are no guidelines or recommendations for the use of NGS in patients with metastatic cancer from an Asian perspective. In this article, we present the Asia-Pacific Oncology Drug Development Consortium (APODDC) recommendations for the clinical use of NGS in metastatic cancers. METHODS The APODDC set up a group of experts in the field of clinical cancer genomics to (i) understand the current NGS landscape for metastatic cancers in the Asia-Pacific (APAC) region; (ii) discuss key challenges in the adoption of NGS testing in clinical practice; and (iii) adapt/modify the European Society for Medical Oncology guidelines for local use. Nine cancer types [breast cancer (BC), gastric cancer (GC), nasopharyngeal cancer (NPC), ovarian cancer (OC), prostate cancer, lung cancer, and colorectal cancer (CRC) as well as cholangiocarcinoma and hepatocellular carcinoma (HCC)] were identified, and the applicability of NGS was evaluated in daily practice and/or clinical research. Asian ethnicity, accessibility of NGS testing, reimbursement, and socioeconomic and local practice characteristics were taken into consideration. RESULTS The APODDC recommends NGS testing in metastatic non-small-cell lung cancer (NSCLC). Routine NGS testing is not recommended in metastatic BC, GC, and NPC as well as cholangiocarcinoma and HCC. The group suggested that patients with epithelial OC may be offered germline and/or somatic genetic testing for BReast CAncer gene 1 (BRCA1), BRCA2, and other OC susceptibility genes. Access to poly (ADP-ribose) polymerase inhibitors is required for NGS to be of clinical utility in prostate cancer. Allele-specific PCR or a small-panel multiplex-gene NGS was suggested to identify key alterations in CRC. CONCLUSION This document offers practical guidance on the clinical utility of NGS in specific cancer indications from an Asian perspective.
Collapse
Affiliation(s)
- H H Loong
- Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China
| | - T Shimizu
- Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University Graduate School of Medicine, Wakayama, Japan
| | - A Prawira
- Cancer Trials and Research Unit, Prince of Wales Hospital, Sydney, Australia
| | - A C Tan
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore
| | - B Tran
- Department of Oncology, Peter MacCallum Cancer Centre, Melbourne
| | - D Day
- Department of Oncology, Monash Health and Monash University, Australia
| | - D S P Tan
- Department of Haematology-Oncology, National University Cancer Institute, Singapore
| | - F I L Ting
- Department of Medicine, Dr. Pablo O. Torre Memorial Hospital, Bacolod, Philippines
| | - J W Chiu
- Department of Medicine, The University of Hong Kong, HKSAR, Pok Fu Lam, Hong Kong, China
| | - M Hui
- Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, Australia
| | - M K Wilson
- Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand
| | - N Prasongsook
- Division of Medical Oncology, Phramongkutklao Hospital, Bangkok, Thailand
| | - T Koyama
- Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan
| | - T Reungwetwattana
- Division of Medical Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - T J Tan
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore
| | - V Heong
- Department Medical Oncology, Tan Tock Seng Hospital, Singapore
| | - P J Voon
- Radiotherapy and Oncology Department, Hospital Umum Sarawak, Kuching, Malaysia
| | - S Park
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - I B Tan
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore
| | - S L Chan
- Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China
| | - D S W Tan
- Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
| |
Collapse
|
5
|
Sekine Y, Kamada K, Koyama T, Hoshikawa S, Ito E, Uchino S, Komatsu T. Effect of the COVID-19 Pandemic on Lower Extremity Injuries in Japanese Collegiate Men's Basketball Players. Orthop J Sports Med 2023; 11:23259671231173367. [PMID: 37275779 PMCID: PMC10233590 DOI: 10.1177/23259671231173367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2023] [Accepted: 02/22/2023] [Indexed: 06/07/2023] Open
Abstract
Background The coronavirus disease 2019 (COVID-19) pandemic significantly affected the lives of Japanese collegiate men's basketball players. Purpose To describe the incidence of lower extremity injuries in Japanese collegiate men's basketball during the COVID-19 pandemic and examine the effects of the pandemic on injury patterns. Study Design Descriptive epidemiological study. Methods Using data from a surveillance project of the Department of Medicine and Science of the Kanto Collegiate Basketball Federation, the authors included data from 6 men's basketball teams during the 2020-21 and 2021-22 seasons (11 team seasons). Injury rates per 1000 athlete-exposures (AEs) were calculated according to injury type, location, and frequency. Injury burden was estimated by multiplying the injury rate by the mean days lost. Injuries from the 2020-21 to 2021-22 seasons were compared with those before the pandemic (2013-14 to 2019-20 seasons) using injury rate ratios (IRRs), with significant differences indicated when the 95% CI did not include 1.0. Results In total, 135 lower extremity injuries were reported during 27,249 AEs. The overall injury rate of the 2020-21 to 2021-22 seasons was significantly higher than that of the 2013-14 to 2019-20 seasons (IRR, 1.37; 95% CI, 1.12-1.67). Lateral ankle sprains (IRR, 1.37; 95% CI, 1.02-1.86), hamstring strains (IRR, 2.86; 95% CI, 1.34-6.12), jumper's knee (IRR, 2.68; 95% CI, 1.13-6.37), and stress fractures of the proximal fifth metatarsal (IRR, 7.16; 95% CI, 1.31-39.08) were significantly higher during the 2020-21 to 2021-22 seasons compared with the 2013-14 to 2019-20 seasons. Conclusion The rate of lower extremity injuries increased significantly in Japanese collegiate men's basketball players during the COVID-19 pandemic. The results of this study emphasize the importance of optimal screening and specific loads for injury prevention when detraining periods are anticipated.
Collapse
Affiliation(s)
- Yuta Sekine
- Faculty of Humanities and Social
Sciences, Teikyo Heisei University, Nakano-ku, Tokyo, Japan
- Faculty of Sports and Health Science,
Daito Bunka University, Higashimatsuyama-shi, Saitama, Japan
- Department of Medicine and Science,
Kanto Collegiate Basketball Federation, Shibuya-ku, Tokyo, Japan
| | - Kotaro Kamada
- Department of Medicine and Science,
Kanto Collegiate Basketball Federation, Shibuya-ku, Tokyo, Japan
- Graduate School of Sport Sciences,
Waseda University, Tokorozawa-shi, Saitama, Japan
| | - Takeshi Koyama
- Department of Medicine and Science,
Kanto Collegiate Basketball Federation, Shibuya-ku, Tokyo, Japan
- Department of Competitive Sports,
School of Physical Education, Tokai University, Hiratsuka-shi, Kanagawa, Japan
| | - Seigo Hoshikawa
- Department of Medicine and Science,
Kanto Collegiate Basketball Federation, Shibuya-ku, Tokyo, Japan
- School of Social Informatics, Aoyama
Gakuin University, Sagamihara-shi, Kanagawa, Japan
| | - Eri Ito
- Department of Medicine and Science,
Kanto Collegiate Basketball Federation, Shibuya-ku, Tokyo, Japan
- Department of Sports Medicine, Faculty
of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| | - Sayuri Uchino
- Department of Sports Medicine, Faculty
of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
- Department of Sports Medicine, Faculty
of Health and Sports Science, Juntendo University, Inzai-shi, Chiba, Japan
| | - Takayuki Komatsu
- Department of Medicine and Science,
Kanto Collegiate Basketball Federation, Shibuya-ku, Tokyo, Japan
- Department of Sports Medicine, Faculty
of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan
| |
Collapse
|
6
|
Koyama K, Kubo T, Koyama T, Takahashi Y. The parity affects the relationship between the insemination-ovulation interval and the conception rate in lactating dairy cows. Reprod Domest Anim 2023. [PMID: 37081602 DOI: 10.1111/rda.14363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2023] [Revised: 04/12/2023] [Accepted: 04/16/2023] [Indexed: 04/22/2023]
Abstract
The aim of the present study was to investigate the relationship between parity and the optimal insemination-ovulation interval (IOI) in lactating dairy cows, as well as the relationship between the optimal timing of artificial insemination (AI) based on the onset of estrus and parity. A total of 183 postpartum lactating Holstein cows participated in the study and underwent 522 AI procedures using unsorted frozen semen between 2011 and 2018. Transrectal ultrasound was used to detect ovulation times in 326 AI procedures, and a pedometer was used to detect estrus onset times in 470 AI procedures. An analysis was also performed on data from 265 AI procedures in which all the times of estrus onset, estrus end, and ovulation were detected. The results showed that ovulation occurring 6-12 hr after AI was associated with the numerical highest conception rate in multiparous cows. Moreover, the conception rate was higher when ovulation occurred between 6 and 12 hr after AI than when it occurred between 0 and 6 hr or 18 and 24 hr after AI. In contrast, the effect of IOI on the conception rate in primiparous cows was insignificant. There was no effect of AI timing based on the estrus onset on the conception rate in either primiparous or multiparous cows. Furthermore, the interval from estrus onset to ovulation was similar in primiparous and multiparous cows. The difference in optimal IOI between primiparous and multiparous cows may be due to the larger uterus size in multiparous cows. These findings suggest that the optimal timing for AI in multiparous cows is more restricted than in primiparous cows. Therefore, it is essential to carefully determine the timing of AI when it is performed in multiparous cows.
Collapse
Affiliation(s)
- Keisuke Koyama
- Laboratory of Theriogenology, Graduate School of Veterinary Science, Osaka Metropolitan University, Izumisano, Osaka, Japan
- Dairy Cow Group, Daily Research Center, Hokkaido Research Organization, Nakashibetsu, Hokkaido, Japan
| | - Tomoaki Kubo
- Dairy Cow Group, Daily Research Center, Hokkaido Research Organization, Nakashibetsu, Hokkaido, Japan
| | - Takeshi Koyama
- Dairy Cow Group, Daily Research Center, Hokkaido Research Organization, Nakashibetsu, Hokkaido, Japan
- Animal Biotechnology Group, Animal Research Center, Hokkaido Research Organization, Shintoku, Hokkaido, Japan
| | | |
Collapse
|
7
|
Kondo S, Koyama T, Kawazoe A, Iwasa S, Yonemori K, Shitara K, Nakamura Y, Saori M, Yamamoto N, Sato J, Sahara T, Hayata N, Yamamuro S, Kimura T, Dutta L, Tamai T, Ikeda M. 401P A phase Ib study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients (pts) with advanced solid tumors. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
8
|
Doi T, Patel M, Falchook G, Koyama T, Friedman C, Piha-Paul S, Gutierrez M, Abdul-Karim R, Awad M, Adkins D, Takahashi S, Kadowaki S, Cheng B, Ikeda N, Laadem A, Yoshizuka N, Qian M, Dosunmu O, Arkenau HT, Johnson M. 453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
9
|
Ware L, Koyama T, Nguyen J, Swain S, Kukreja J, Dhillon G, Weigt S, Singer J, Matthay M. Randomized Trial of Protective Lung Ventilation in Organ Donors. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
10
|
Sekine Y, Kamada K, Koyama T, Hoshikawa S, Uchino S, Komatsu T. Descriptive epidemiology of injuries in Japanese collegiate men's basketball: 2013/2014 to 2019/2020. Inj Epidemiol 2022; 9:4. [PMID: 35039081 PMCID: PMC8762943 DOI: 10.1186/s40621-022-00368-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Accepted: 12/29/2021] [Indexed: 11/22/2022] Open
Abstract
Background Basketball is one of the most played sports in the world. However, only a few studies have examined the epidemiology of Japanese collegiate men’s basketball injuries. This study investigated the incidence of injury among Japanese collegiate men’s basketball from the 2013/2014 to the 2019/2020 seasons and identified unique patterns by comparing our data with the National Collegiate Athletic Association (NCAA) men’s basketball data. Methods Data from Japanese collegiate basketball teams of the Kanto Collegiate Basketball Federation Division I League during the 2013/2014 to 2019/2020 academic years (23 team-seasons) were used in this study. Injury rates per 1000 athlete exposures (AEs), injury proportions, and the injury rate ratio (IRR) were calculated according to the events, injury types, body parts, and common injury mechanisms. Injury rates were then compared with that from the time-loss injury data of the NCAA’s previous reports. Results In total, 480 injuries during 97,515 AEs were reported, leading to an injury rate of 4.92 per 1000 AEs (95% CI = 4.48–5.36). The overall injury rate was higher in Japan than in the NCAA ([2009/2010–2014/2015] IRR = 1.55, 95% CI = 1.39–1.73; [2014/2015–2018/2019] IRR = 1.64, 95% CI = 1.48–1.82). Lower extremity injuries occurred most frequently (73.5%). Ankle sprain was the most common injury in Japan, with higher injury rates than in the NCAA (IRR = 2.10; 95% CI = 1.72–2.57). The injury rate of concussion was lower in Japan than in the NCAA (IRR = 0.28; 95% CI = 0.14–0.55). Conclusions The rates of overall injury and ankle sprain were higher and that of concussion was lower in Japan than in the NCAA. These results suggested the existence of international differences in the pattern or features of injuries in basketball players.
Collapse
Affiliation(s)
- Yuta Sekine
- Faculty of Modern Life, Teikyo Heisei University, 4-21-2 Nakano, Nakano-ku, Tokyo, 164-8530, Japan. .,Faculty of Sports and Health Science, Daito Bunka University, 560 Iwadono, Higashimatsuyama-shi, Saitama, 355-8501, Japan. .,Department of Medicine and Science, Kanto Collegiate Basketball Federation, 27-2 Sakuragaoka-cho, Shibuya-ku, Tokyo, 150-0031, Japan.
| | - Kotaro Kamada
- Graduate School of Sport Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa-shi, Saitama, 359-1192, Japan
| | - Takeshi Koyama
- Sports Medical Science Research Institute, Tokai University, 4-1-1 Kitakaname, Hiratsuka-shi, Kanagawa, 259-1292, Japan.,Department of Medicine and Science, Kanto Collegiate Basketball Federation, 27-2 Sakuragaoka-cho, Shibuya-ku, Tokyo, 150-0031, Japan
| | - Seigo Hoshikawa
- School of Social Informatics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Sagamihara-shi, Kanagawa, 252-5258, Japan.,Department of Medicine and Science, Kanto Collegiate Basketball Federation, 27-2 Sakuragaoka-cho, Shibuya-ku, Tokyo, 150-0031, Japan
| | - Sayuri Uchino
- Department of Orthopaedics, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan
| | - Takayuki Komatsu
- Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima-ku, Tokyo, 177-8521, Japan.,Department of Medicine and Science, Kanto Collegiate Basketball Federation, 27-2 Sakuragaoka-cho, Shibuya-ku, Tokyo, 150-0031, Japan
| |
Collapse
|
11
|
Kageyama H, Asaka K, Kishida H, Koyama T. Hole Doping in Polythiophenes Encapsulated in Semiconducting and Metallic Single-Walled Carbon Nanotubes: Impact of the Electronic Structure. Macromolecules 2021. [DOI: 10.1021/acs.macromol.1c01922] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Hiroto Kageyama
- Department of Applied Physics, Nagoya University, Chikusa, Nagoya 464-8603, Japan
| | - Koji Asaka
- Department of Applied Physics, Nagoya University, Chikusa, Nagoya 464-8603, Japan
| | - Hideo Kishida
- Department of Applied Physics, Nagoya University, Chikusa, Nagoya 464-8603, Japan
| | - Takeshi Koyama
- Department of Applied Physics, Nagoya University, Chikusa, Nagoya 464-8603, Japan
| |
Collapse
|
12
|
Sasaki S, Nagano Y, Suganuma Y, Koyama T, Ichikawa H. Acceleration profile of high-impact movements during young football games: a cross-sectional study involving healthy children. Sports Biomech 2021:1-15. [PMID: 34490829 DOI: 10.1080/14763141.2021.1970796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Accepted: 08/16/2021] [Indexed: 10/20/2022]
Abstract
Repetitive high-impact movements cause growth-related injuries in children. This study aimed to identify which movements during junior football games require >6 G and >8 G acceleration and the frequency at which they occur. Additionally, we compared the components of acceleration among movements with >8 G resultant acceleration. Eleven young male footballers (10.7 ± 0.4 years) played 8-a-side games while wearing a tri-axial accelerometer on their upper back. The number and frequency of the movements that generated >6 G and >8 G were calculated, and each directive acceleration of the top five items was compared using two-way ANOVA to examine the effect of movements. The frequency of movements that generated >6 G and >8 G acceleration during junior football games was 8.70 case/min and 2.62 case/min, respectively. The top five >8 G movements were braking and pre-braking in shuffle, slowdown, stop, and run/jog items. The vertical acceleration was significantly greater during braking in shuffle than during slowdown, stop, and run/jog and also greater during stop and pre-braking in shuffle than during run/jog movement. This pilot study suggests that decelerated movements mainly provoked high-impact situations and may be key actions for preventing overuse injury in young footballers.
Collapse
Affiliation(s)
- Shogo Sasaki
- Faculty of Health Sciences, Tokyo Ariake University of Medical and Health Sciences, Tokyo, Japan
| | - Yasuharu Nagano
- Department of Sports and Health Science, Japan Women's College of Physical Education, Tokyo, Japan
| | - Yusaku Suganuma
- Graduate School of Health Sciences, Tokyo Ariake University of Medical and Health Sciences, Tokyo, Japan
| | - Takeshi Koyama
- Sports Medical Science Research Institute, Tokai University, Tokyo, Japan
| | - Hiroshi Ichikawa
- Department of Health and Sports, Niigata University of Health and Welfare, Niigata, Japan
| |
Collapse
|
13
|
Kage H, Sunami K, Naito Y, Amano T, Ennishi D, Imai M, Kanai M, Kenmotsu H, Komine K, Koyama T, T. M, Morita S, Saigusa Y, Sakai D, Yamanaka T, Kohsaka S, Tsuchihara K, Yoshino T. 519MO Concordance analysis of treatment recommendations between central consensus and multidisciplinary tumor boards. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
14
|
Kojima Y, Shimizu T, Yonemori K, Koyama T, Matsui N, Kamikura M, Tomatsuri S, Okuma H, Shimoi T, Noguchi E, Sudo K, Hirakawa A, Sadachi R, Okita N, Nakamura K, Yamamoto N, Fujiwara Y. 1521O A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultra-rare cancer with highly life-threatening unmet medical needs (NCCH1806/MK004). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
15
|
Komine K, Sunami K, Naito Y, Amano T, Ennishi D, Imai M, Kage H, Kanai M, Kenmotsu H, Koyama T, T. M, Morita S, Sakai D, Kohsaka S, Tsuchihara K, Saigusa Y, Yamanaka T, Yoshino T. 551P Chronological improvement in precision oncology implementation in Japan. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
16
|
Kitada T, Kadoba K, Watanabe R, Koyama T, Nakayama Y, Taki M, Yukawa S, Odani K, Morinobu A. Listeriosis presenting with fever, arthralgia, elevated liver enzymes, and hyperferritinaemia in pregnancy: a critical mimicker of adult-onset Still's disease. Scand J Rheumatol 2021; 51:78-80. [PMID: 34152237 DOI: 10.1080/03009742.2021.1923149] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- T Kitada
- Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.,These authors contributed equally to this work
| | - K Kadoba
- Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.,These authors contributed equally to this work
| | - R Watanabe
- Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - T Koyama
- Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, Kyoto, Japan.,Department of Infectious Diseases, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan
| | - Y Nakayama
- Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - M Taki
- Department of Gynecology and Obstetrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - S Yukawa
- Department of Infection Control and Prevention, Kyoto University Hospital, Kyoto, Japan
| | - K Odani
- Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
| | - A Morinobu
- Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| |
Collapse
|
17
|
Yoshida T, Hashimoto M, Murakami K, Murata K, Nishitani K, Watanabe R, Koyama T, Uehara R, Tanaka M, Ito H, Matsuda S. POS1482-HPR PAIN CATASTROPHIZING IS ASSOCIATED WITH RESIDUAL PAIN AFTER REACHING IMPROVED CONDITIONS OF SWOLLEN/TENDER JOINTS AND SERUM C-REACTIVE PROTEIN LEVEL. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.1723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:It has long been recognized that immune-mediated inflammatory diseases, such as rheumatoid arthritis (RA), are prone to coexist with depression due to the effects of cytokines, and that these two illnesses lead to an elevation in patients’ pain. However, we often encounter patients with RA who suffer from residual pain despite an improvement in disease activity and inflammation. The specific psychological factors associated with residual pain have not yet been clarified. In addition to the traditional psychological factors, such as depression and anxiety, we focused on pain catastrophizing due to the distortion of pain perception and explored its association with residual pain.Objectives:To examine whether psychological factors, such as pain catastrophizing, depression, and anxiety, are associated with self-reported pain visual analogue scale (pain-VAS) scores in RA patients with 1 or less on 28joints- swollen/tender counts (SJC/TJC) and CRP.Methods:This was a cross-sectional study of 290 RA outpatients (85% of whom were women) with scores of less than 1 on SJC, TJC, and CRP, with a median (IQR) age of 66 (57–73) years. The participants completed questionnaires, including pain VAS (0–100 mm), Pain Catastrophizing Scale (PCS, 0–52 scale), and Hospital Depression and Anxiety Scale (HADS, 0–42 scale). Using linear regression analyses, we analysed whether PC (PCS ≥30), depression (HADS-D ≥11), and anxiety (HADS-A ≥11) (independent variables) were associated with pain VAS scores (dependent variable). After univariate regression analysis, multivariate analysis adjusted for confounding factors was performed.Results:Patients reported a wide range of pain severity with a median (range) pain VAS score of 9 (0–96mm). The prevalence of anxiety and depression were 5.5% and 5.9%, respectively. Meanwhile, 24.1% of the patients experienced pain catastrophizing. Pain catastrophizing was associated with pain VAS scores in univariate and multivariate analyses (Table 1). The presence of anxiety and depression was not associated with pain VAS scores in any model. Multivariate analysis of other covariates showed that age, disease duration, and presence of SJC/TJC of joints other than the 28 joints were positively correlated with pain VAS scores.Table 1.Univariate and multivariate regression analysis for independent variables associated with pain-VAS scoresUnivariateMultivariate independent variablesModel 1*Model 2**Pain catastrophizingEstimate3.74.13.695%CI 0.7 to 6.61.1 to 7.00.5 to 6.6p-value0.0150.0060.021AnxietyEstimate3.74.40.595%CI -1.9 to 9.2 -1.0 to 9.9 -3.5 to 7.9p value0.1980.1080.453DepressionEstimate3.54.23.995%CI -1.9 to 8.9 -1.1 to 9.5 -1.9 to 8.7p-value0.2040.1190.210The covariates in multivariate analysis are as follows: age, sex, body mass index, disease duration, Steinbrocker’s Stage, prednisolone dosage, biologic agents use, and presence of swollen joint counts/tender joint counts of joints other than the 28 joints.*Model 1: each psychological independent variable and the above covariates.**Model 2: all psychological independent variables and the above covariates.Conclusion:Pain catastrophizing was associated with pain VAS scores in RA patients with 1 or less on 28joints-SJC/TJC and CRP, emphasising that residual pain in the patients should be treated in a biopsychosocial framework focussing on pain catastrophizing.Disclosure of Interests:Tamami Yoshida: None declared, Motomu Hashimoto Speakers bureau: Mitsubishi Tanabe Pharma Corporation; Bristol-Myers Squibb; Eisai Co., Ltd.; and Eli Lilly and Company., Grant/research support from: Mitsubishi Tanabe Pharma Corporation; Bristol-Myers Squibb; Eisai Co., Ltd.; and Eli Lilly and Company., Kosaku Murakami Speakers bureau: Eisai Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Pfizer Inc.; Bristol-Myers Squibb; Mitsubishi Tanabe Pharma Co; UCB Japan Co., Ltd.; Daiichi Sankyo Co., Ltd.; and Astellas Pharma Inc., Consultant of: Eisai Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Pfizer Inc.; Bristol-Myers Squibb; Mitsubishi Tanabe Pharma Co; UCB Japan Co., Ltd.; Daiichi Sankyo Co., Ltd.; and Astellas Pharma Inc., Koichi Murata Speakers bureau: Eisai Co., Ltd. and Astellas Pharma Inc., Consultant of: Eisai Co., Ltd. and Astellas Pharma Inc., Kohei Nishitani Grant/research support from: Asahi-Kasei Pharma., Ryu Watanabe Speakers bureau: Mitsubishi Tanabe Pharma Co; Pfizer Inc.; Sanofi S.A.; AbbVie GK; Asahi Kasei Pharma; Eisai Co., Ltd.; Eli Lilly and Company; Bristol-Myers Squibb; and Janssen Pharmaceutical K.K., Teruhide Koyama: None declared, Ritei Uehara: None declared, Masao Tanaka Speakers bureau: AbbVie GK, Asahi Kasei Pharma., Astellas Pharma Inc., Ayumi Pharmaceutical Co., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Novartis Pharma K.K., Pfizer Inc., Taisyo Pharma., Ltd., UCB Japan Co., Ltd., Grant/research support from: AbbVie GK, Asahi Kasei Pharma., Astellas Pharma Inc., Ayumi Pharmaceutical Co., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Co., Novartis Pharma K.K., Pfizer Inc., Taisyo Pharma., Ltd., UCB Japan Co., Ltd., Hiromu Ito Grant/research support from: Bristol-Myers Squibb, Eisai Co, Taisyo Pharma., and Mochida., Shuichi Matsuda: None declared
Collapse
|
18
|
Nagano Y, Sasaki S, Shimada Y, Koyama T, Ichikawa H. High-Impact Details of Play and Movements in Female Basketball Game. Sports Med Int Open 2021; 5:E22-E27. [PMID: 33553596 PMCID: PMC7857967 DOI: 10.1055/a-1309-3085] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Accepted: 11/11/2020] [Indexed: 11/06/2022] Open
Abstract
This study aimed to identify the high-impact details of play and movements
with higher acceleration and their frequency during a female basketball
match. Trunk acceleration was measured during a simulated basketball game
with eight female players. The extracted instance was categorized, which
generated at > 6 and 8 G resultant accelerations using a
video recording and an accelerometer attached to the players’ trunk,
as details of play and movements. The frequency and ratio of the details of
play and movements regarding all detected movements were calculated. A total
of 1062 and 223 play actions were detected for the resultant acceleration
thresholds of > 6 and 8 G, respectively. For these
acceleration thresholds, in terms of details of play, positioning on the
half-court was the most frequently observed (29.6 and 23.8%,
respectively). In terms of movements, deceleration was the most frequently
detected movement (21.5 and 23.3%, respectively), followed by
landing (7.6 and 15.7%, respectively). Deceleration during
positioning on the half-court and defense as well as landing mostly after a
shot were detected as high-impact frequent basketball-specific movements.
The results also showed that characteristics of movements or playing style
and playing position may have an effect on acceleration patterns during a
basketball game.
Collapse
Affiliation(s)
- Yasuharu Nagano
- Department of Sports and Health Science, Japan Women's College of Physical Education, Tokyo, Japan
| | - Shogo Sasaki
- Faculty of Health Sciences, Tokyo Ariake University of Medical and Health Sciences, Tokyo, Japan
| | - Yui Shimada
- Faculty of Health Sciences, Tokyo Ariake University of Medical and Health Sciences, Tokyo, Japan
| | - Takeshi Koyama
- Sports Medical Science Research Institute, Tokai University, Kanagawa, Japan
| | - Hiroshi Ichikawa
- Department of Health and Sports, Niigata University of Health and Welfare, Niigata, Japan
| |
Collapse
|
19
|
Pasalic D, Barocas D, Zhao Z, Huang L, Koyama T, Tang C, Penson D, Hoffman K. Patient-Reported Outcomes through Five Years following External Beam Radiotherapy or External Beam Radiotherapy with Low-Dose-Rate Brachytherapy Boost for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Oka T, Kamada R, Kunimasa K, Oboshi M, Nishikawa T, Yasui T, Shioyama W, Miyashita Y, Koyama T, Kumagai T, Fujita M. Pathological assessment of osimertinib-associated cardiotoxicity in EGFR-mutated non-small cell lung cancer patients. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0881] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Osimertinib, a third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI), inhibits both EGFR-TKI sensitizing mutations and resistant T790M mutations detected in non-small cell lung cancer (NSCLC) patients. Cardiac adverse events (AEs) induced by osimertinib are infrequent; however, cases of severe associated cardiac dysfunction have been reported and remain poorly understood.
Purpose
To assess pathogenesis of osimertinib-associated cardiac AEs, we analyzed myocardial specimens of three NSCLC cases with osimertinib-associated cardiac dysfunction.
Results
Analysis of LVEF prior to and after osimertinb administration in 36 NSCLC patients showed significant decrease of LVEF from 69% to 63%. Within this cohort, right ventricular (RV) biopsy was performed in 2 cases to further understand the pathophysiology of cardiac dysfunction. Case 1 was 78-year-old female with advanced NSCLC harboring an EGFR L858R mutation was treated with osimertinib as second line therapy. After 3 moths of osimetinib treatment, she presented with dyspnea, high NT-proBNP and troponin I, and significantly decreased left ventricular ejection fraction (LVEF) at 28%. RV biopsy showed moderate cardiomyocyte hypertrophy without inflammatory cell infiltration. Case 2 was 52-year-old female with advanced NSCLC harboring L858R mutation. She was treated with osimertinib as first line therapy. After 2 weeks of osimertinib, screening echocardiography revealed a reduction of LVEF from 63% to 41% without cardiac symptom. RV biopsy showed mild cardiomyocyte hypertrophy with infiltration of a few inflammatory cells in interstinum. We further analyzed death case of NSCLC. Case 3 was 63-year-old female with advanced NSCLC harboring EGFR ex. 19 del. and T790M mutations. After 6 months of osimertinib, she suffered from severe respiratory failure and severely reduced LVEF at 27%. She died on the 44th day after admission. Pathological autopsy revealed mild to moderate cardiomyocyte hypertrophy without inflammatory cell infiltration in both ventricles. These pathological findings may indicate neither myocyte injury nor myocarditis was induced by osimertinib in myocardium.
Conclusion
Although additional data collection of advanced NSCLC patients will be important in understanding the pathophysiology of cardiac AEs with osimertinib, osimertinib-associated cardiotoxicity may result from functional inhibition of myocyte contractility by osimertinib without induction of cell death or inflammation.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- T Oka
- Osaka International Cancer Institute, Department of Onco-Cardiology, Osaka, Japan
| | - R Kamada
- Osaka International Cancer Institute, Department of Onco-Cardiology, Osaka, Japan
| | - K Kunimasa
- Osaka International Cancer Institute, Department of Thoracic Oncology, Osaka, Japan
| | - M Oboshi
- Osaka International Cancer Institute, Department of Onco-Cardiology, Osaka, Japan
| | - T Nishikawa
- Osaka International Cancer Institute, Department of Onco-Cardiology, Osaka, Japan
| | - T Yasui
- Osaka International Cancer Institute, Department of Onco-Cardiology, Osaka, Japan
| | - W Shioyama
- Osaka International Cancer Institute, Department of Onco-Cardiology, Osaka, Japan
| | - Y Miyashita
- Yamanashi Prefectural Central Hospital, Department of Pneumology, Kofu, Japan
| | - T Koyama
- Yamanashi Prefectural Central Hospital, Department of Pathology, Kofu, Japan
| | - T Kumagai
- Osaka International Cancer Institute, Department of Thoracic Oncology, Osaka, Japan
| | - M Fujita
- Osaka International Cancer Institute, Department of Onco-Cardiology, Osaka, Japan
| |
Collapse
|
21
|
Affiliation(s)
- Takahiro Suzuki
- Department of Chemistry, Faculty of Science, Hokkaido University, Sapporo, 060-0810 Hokkaido, Japan
| | - Takeshi Koyama
- Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo, 060-0810 Hokkaido, Japan
| | - Kenta Nakanishi
- Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo, 060-0810 Hokkaido, Japan
| | - Susumu Kobayashi
- Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
| | - Keiji Tanino
- Department of Chemistry, Faculty of Science, Hokkaido University, Sapporo, 060-0810 Hokkaido, Japan
| |
Collapse
|
22
|
Koyama T, Rikukawa A, Nagano Y, Sasaki S, Ichikawa H, Hirose N. Acceleration Profile of High-Intensity Movements in Basketball Games. J Strength Cond Res 2020; 36:1715-1719. [PMID: 32639378 DOI: 10.1519/jsc.0000000000003699] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Koyama, T, Rikukawa, A, Nagano, Y, Sasaki, S, Ichikawa, H, and Hirose, N. Acceleration profile of high-intensity movements in basketball games. J Strength Cond Res XX(X): 000-000, 2020-This study aimed to elucidate movements that require greater acceleration during basketball games, their occurrence frequency, and compare acceleration components. Eighteen male collegiate basketball players (age: 19.5 ± 0.8 years) were enrolled. Triaxial accelerometer was used to measure acceleration and a synchronized video was recorded. Moments that generated resultant accelerations >4, 6, and 8 G, and their coincided movements were identified. Ratios and frequencies of the extracted movements were calculated and Jonckheere-Terpstra trend test was used to examine which movement rate increased when acceleration threshold increased. In addition, the top 7 movements that generated a resultant acceleration >6 G among the combination of basketball-specific movements were extracted. Their resultant, mediolateral, vertical, and anteroposterior accelerations were identified and compared using one-way analysis of variance. Cohen's d was used to calculate effect sizes. All p < 0.05 were considered statistically significant. The extracted frequencies were 33.6, 9.1, and 2.3 cases per minute for >4 G, >6 G, and >8 G, respectively. As the threshold increased, the rate of deceleration, landing, and physical contact increased. The mediolateral acceleration of physical contact was significantly greater than other movements, whereas the vertical acceleration of landing and deceleration was significantly greater than other movements. Thus, acceleration component analysis was performed to classify movement types. Greater acceleration appeared frequently in movement during defense. It is suggested that many defense movements involve a reaction to the ball and opponent. There are many passive movements during defense and speed changes rapidly. If many passive movements occur when defending, larger physical load is applied, and may lead to fatigue.
Collapse
Affiliation(s)
- Takeshi Koyama
- Sports Medical Science Research Institute, Tokai University, Tokyo, Japan.,Graduate School of Sport Sciences, Waseda University, Tokyo, Japan
| | - Akira Rikukawa
- Department of Competitive Sports, Tokai University, Tokyo, Japan
| | - Yasuharu Nagano
- Department of Sports and Health Science, Japan Women's College of Physical Education, Tokyo, Japan
| | - Shogo Sasaki
- Faculty of Health Sciences, Tokyo Ariake University of Medical and Health Sciences, Tokyo, Japan
| | - Hiroshi Ichikawa
- Department of Health and Sports, Niigata University of Health and Welfare, Niigata, Japan
| | | |
Collapse
|
23
|
Imamura Y, Kiyota N, Suzuki C, Koyama T, Kimbara S, Shinomiya H, Otsuki N, Hasegawa T, Toyoda M, Funakoshi Y, Akashi M, Sasaki R, Nibu K, Minami H. Prognostic value of the modified Glasgow Prognostic Score for head and neck cancer in the era of immunotherapy. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2019.11.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Sato J, Shimizu T, Fujiwara Y, Yonemori K, Koyama T, Shimomura A, Tamura K, Iwasa S, Kondo S, Sudo K, Ikezawa H, Nomoto M, Nakajima R, Miura T, Yamamoto N. 17O A first-in-human phase I study of MORAb-202 in patients with folate receptor alpha-positive advanced solid tumors. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.01.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
25
|
Imamine R, Okumura A, Ito H, Yamamoto Y, Ishizaka Y, Sakata E, Okumura N, Koyama T. Abstract No. 588 Success rate and complications of indocyanine green and lipiodol mixture with fat emulsion for computed tomography–guided pulmonary marking before video-assisted thoracic surgery: a retrospective comparison with short hook wire. J Vasc Interv Radiol 2020. [DOI: 10.1016/j.jvir.2019.12.649] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
26
|
Baron P, Cornet S, Collins E, DeAngelis G, Del Cul G, Fedorov Y, Glatz J, Ignatiev V, Inoue T, Khaperskaya A, Kim I, Kormilitsyn M, Koyama T, Law J, Lee H, Minato K, Morita Y, Uhlíř J, Warin D, Taylor R. A review of separation processes proposed for advanced fuel cycles based on technology readiness level assessments. Progress in Nuclear Energy 2019. [DOI: 10.1016/j.pnucene.2019.103091] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
27
|
Koyama T, Tsubota A, Sawano T, Tawa M, Watanabe B, Hiratake J, Nakagawa K, Matsumura Y, Ohkita M. Involvement of γ-Glutamyl Transpeptidase in Ischemia/Reperfusion-Induced Cardiac Dysfunction in Isolated Rat Hearts. Biol Pharm Bull 2019; 42:1947-1952. [DOI: 10.1248/bpb.b19-00434] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Takeshi Koyama
- Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
| | - Akari Tsubota
- Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
| | - Tatsuya Sawano
- Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
- Division of Pharmacology, Faculty of Medicine, Tottori University
| | - Masashi Tawa
- Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
- Department of Pharmacology, Kanazawa Medical University
| | | | - Jun Hiratake
- Institute for Chemical Research, Kyoto University
| | - Keisuke Nakagawa
- Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
| | - Yasuo Matsumura
- Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
| | - Mamoru Ohkita
- Laboratory of Pathological and Molecular Pharmacology, Osaka University of Pharmaceutical Sciences
| |
Collapse
|
28
|
Yamazaki K, Koyama T, Shimizu T, Takahashi T, Watanabe J, Tanaka Y, Myobudani H, Yamamoto N. Phase I study of BI 836880, a VEGF/Ang2-blocking nanobody®, as monotherapy and in combination with BI 754091, an anti-PD-1 antibody, in Japanese patients (pts) with advanced solid tumours. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz420.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
Yamamoto N, Sato J, Koyama T, Iwasa S, Shimomura A, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Tamura K, Suzuki T, Takase T, Nishiwaki Y, Nakai K, Shimizu T. Phase I study of liposomal formulation of eribulin (E7389-LF) in patients (pts) with advanced solid tumours: Primary results of dose-escalation part. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz242.043] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Sato J, Koyama T, Shimizu T, Yamamoto N. High performance of serial tumour biopsies in first in human (FIH) phase I trials. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz244.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
31
|
Yonemori K, Shimizu T, Koyama T, Matsui N, Okuma H, Noguchi E, Sudo K, Hirakawa A, Sukigara T, Fujitani S, Nakamura K, Tamura K, Yamamoto N, Fujiwara Y. A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, a disease with a high unmet need. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz283.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
32
|
Ohnishi T, Kobayashi H, Yajima T, Koyama T, Noguchi K. Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical Setting. Innov Clin Neurosci 2019; 16:11-16. [PMID: 32082943 PMCID: PMC7009330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Objective: While attention-deficit/hyperactivity disorder (ADHD) is associated with a high prevalence of comorbid psychiatric disorders in every age group, the etiology and epidemiology of comorbid disorders are less clear in adult patients with ADHD. In this surveillance study, investigators sought to assess the prevalence of comorbid psychiatric disorders, evaluate relationships between comorbid psychiatric disorders and demographic characteristics, and explore the patterns of these comorbid disorders and their relationships with ADHD subtypes. Methods: Data obtained from postmarketing surveillance of methylphenidate extended-release tablets for adult ADHD were used to evaluate the prevalence of psychiatric comorbidities. Age, sex, age at diagnosis, number of comorbidities, and severity of ADHD symptoms were used as external variables for exploratory analyses. Nonmetric multidimensional scaling (NMDS) was performed to explore correlations among comorbidities and ADHD subtypes and extract major dimensions underlying variations in the pattern of comorbid disorders. Results: Data were collected from 575 patients with adult ADHD, including 301 (52.35%) with at least one concurrent psychiatric disorder. Analysis by NMDS demonstrated that different patterns of psychiatric comorbidities were related to the subtypes of ADHD. Conclusions: Psychiatric comorbidities have a high prevalence in patients with adult ADHD. Understanding these patterns could provide useful information in the diagnosis of adult ADHD and future investigations of its etiology.
Collapse
Affiliation(s)
- Takashi Ohnishi
- Drs. Ohnishi, Kobayashi, and Noguchi are with the Medical Affairs Division, Mr. Yajima is with the Quantitative Science Division, and Mr. Koyama is with the Drug Surveillance Department of the Research and Development Division of Janssen Pharmaceutical K.K. in Tokyo, Japan
| | - Hisanori Kobayashi
- Drs. Ohnishi, Kobayashi, and Noguchi are with the Medical Affairs Division, Mr. Yajima is with the Quantitative Science Division, and Mr. Koyama is with the Drug Surveillance Department of the Research and Development Division of Janssen Pharmaceutical K.K. in Tokyo, Japan
| | - Tsutomu Yajima
- Drs. Ohnishi, Kobayashi, and Noguchi are with the Medical Affairs Division, Mr. Yajima is with the Quantitative Science Division, and Mr. Koyama is with the Drug Surveillance Department of the Research and Development Division of Janssen Pharmaceutical K.K. in Tokyo, Japan
| | - Takeshi Koyama
- Drs. Ohnishi, Kobayashi, and Noguchi are with the Medical Affairs Division, Mr. Yajima is with the Quantitative Science Division, and Mr. Koyama is with the Drug Surveillance Department of the Research and Development Division of Janssen Pharmaceutical K.K. in Tokyo, Japan
| | - Kenichi Noguchi
- Drs. Ohnishi, Kobayashi, and Noguchi are with the Medical Affairs Division, Mr. Yajima is with the Quantitative Science Division, and Mr. Koyama is with the Drug Surveillance Department of the Research and Development Division of Janssen Pharmaceutical K.K. in Tokyo, Japan
| |
Collapse
|
33
|
Nagata M, Shukla S, Nakanishi Y, Liu Z, Lin YC, Shiga T, Nakamura Y, Koyama T, Kishida H, Inoue T, Kanda N, Ohno S, Sakagawa Y, Suenaga K, Shinohara H. Isolation of Single-Wired Transition-Metal Monochalcogenides by Carbon Nanotubes. Nano Lett 2019; 19:4845-4851. [PMID: 30798600 DOI: 10.1021/acs.nanolett.8b05074] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
The successful isolation of single layers from two-dimensional (2D) van der Waals (vdW)-layered materials has opened new frontiers in condensed matter physics and materials science. Their discovery and unique properties laid the foundation for exploring 1D counterparts. However, the isolation of 1D vdW-wired materials has thus far remained a challenge, and effective techniques are demanded. Here we report the facile synthesis of isolated transition-metal monochalcogenide MoTe nanowires by using carbon nanotubes (CNTs) as molds. Individual nanowires are perfectly separated by CNTs with a minimal interaction, enabling detailed characterization of the single wires. Transmission electron microscopy revealed unusual torsional motion of MoTe nanowires inside CNTs. Confinement of 1D vdW-wired materials to the nanotest tubes might open up possibilities for exploring unprecedented properties of the nanowires and their potential applications such as electromechanical switching devices.
Collapse
Affiliation(s)
- Masataka Nagata
- Department of Chemistry , Nagoya University , Nagoya 464-8602 , Japan
| | - Shivani Shukla
- Department of Materials Science and Engineering , Carnegie Mellon University , Pittsburgh , Pennsylvania 15213-3815 , United States
| | - Yusuke Nakanishi
- Department of Chemistry , Nagoya University , Nagoya 464-8602 , Japan
- Institute for Advanced Research , Nagoya University , Nagoya 464-8602 , Japan
- Department of Physics , Tokyo Metropolitan University , Tokyo 192-0397 , Japan
| | - Zheng Liu
- National Institute of Advanced Industrial Science and Technology (AIST) , Nagoya 463-8560 , Japan
- National Institute of Advanced Industrial Science and Technology (AIST) , Tsukuba 305-8565 , Japan
| | - Yung-Chang Lin
- National Institute of Advanced Industrial Science and Technology (AIST) , Tsukuba 305-8565 , Japan
| | - Takuma Shiga
- Department of Mechanical Engineering , The University of Tokyo , Tokyo 113-8656 , Japan
| | - Yuto Nakamura
- Department of Applied Physics , Nagoya University , Nagoya 464-8603 , Japan
| | - Takeshi Koyama
- Department of Applied Physics , Nagoya University , Nagoya 464-8603 , Japan
| | - Hideo Kishida
- Department of Applied Physics , Nagoya University , Nagoya 464-8603 , Japan
| | - Tsukasa Inoue
- Department of Chemistry , Nagoya University , Nagoya 464-8602 , Japan
| | - Naoyuki Kanda
- Department of Chemistry , Nagoya University , Nagoya 464-8602 , Japan
| | - Shun Ohno
- Gifu High School , Gifu 500-8889 , Japan
| | - Yuki Sakagawa
- Ichinomiya High School , Ichinomiya 491-8533 , Japan
| | - Kazu Suenaga
- National Institute of Advanced Industrial Science and Technology (AIST) , Tsukuba 305-8565 , Japan
| | - Hisanori Shinohara
- Department of Chemistry , Nagoya University , Nagoya 464-8602 , Japan
- Institute for Advanced Research , Nagoya University , Nagoya 464-8602 , Japan
| |
Collapse
|
34
|
Sato J, Itahashi K, Shimizu T, Koyama T, Kondo S, Fujiwara Y, Yamamoto N. Dynamic change in the distribution of cancer types in oncology phase I trials. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz026.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
35
|
Togawa Y, Kishine J, Nosov PA, Koyama T, Paterson GW, McVitie S, Kousaka Y, Akimitsu J, Ogata M, Ovchinnikov AS. Anomalous Temperature Behavior of the Chiral Spin Helix in CrNb_{3}S_{6} Thin Lamellae. Phys Rev Lett 2019; 122:017204. [PMID: 31012683 DOI: 10.1103/physrevlett.122.017204] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Revised: 10/19/2018] [Indexed: 06/09/2023]
Abstract
Using Lorentz transmission electron microscopy and small-angle electron scattering techniques, we investigate the temperature-dependent evolution of a magnetic stripe pattern period in thin-film lamellae of the prototype monoaxial chiral helimagnet CrNb_{3}S_{6}. The sinusoidal stripe pattern appears due to formation of a chiral helimagnetic order (CHM) in this material. We found that as the temperature increases, the CHM period is initially independent of temperature and then starts to shrink above the temperature of about 90 K, which is far below the magnetic phase transition temperature for the bulk material T_{c} (123 K). The stripe order disappears at around 140 K, far above T_{c}. We argue that this cascade of transitions reflects a three-stage hierarchical behavior of melting in two dimensions.
Collapse
Affiliation(s)
- Y Togawa
- Department of Physics and Electronics, Osaka Prefecture University, 1-1 Gakuencho, Sakai, Osaka 599-8531, Japan
- School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - J Kishine
- Division of Natural and Environmental Sciences, The Open University of Japan, Chiba 261-8586, Japan
| | - P A Nosov
- Department of Physics, St. Petersburg State University, St. Petersburg 198504, Russia
- NRC Kurchatov Institute, Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - T Koyama
- Department of Materials Science, Osaka Prefecture University, 1-1 Gakuencho, Sakai, Osaka 599-8531, Japan
| | - G W Paterson
- School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - S McVitie
- School of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ United Kingdom
| | - Y Kousaka
- Research Institute for Interdisciplinary Science, Okayama University, Okayama 700-8530, Japan
| | - J Akimitsu
- Research Institute for Interdisciplinary Science, Okayama University, Okayama 700-8530, Japan
| | - M Ogata
- Department of Physics, the University of Tokyo, Hongo, Bunkyo, Tokyo 113-0033, Japan
| | - A S Ovchinnikov
- Institute of Natural Sciences and Mathematics, Ural Federal University, Ekaterinburg 620083, Russia
- Institute for Metal Physics, Ural Division of RAS, Ekaterinburg 620137, Russia
| |
Collapse
|
36
|
Abstract
Ovarian reserve in cattle can be predicted by an indicator, the antral follicle count (AFC), which is easily determined via ovarian ultrasonography. However, the repeatability of AFC
measurements in the same individual taken approximately 1 year apart after first parity remains unclear. This study, thus, aimed to clarify the between-lactation repeatability of AFC after
first parity in dairy cows. We measured the AFC of the same individual cows consecutively across both first and second parity, both second and third parity, and both third and fourth parity
in 31, 37, and 26 heads, respectively. The values of the intraclass correlation coefficients (ICC) for the AFCs in first–second and second–third parity cows were more than 0.8, and the value
of the ICC for the AFCs in third–fourth parity cows was significantly lower than that in first–second parity cows (P = 0.01). Subsequently, based on the average number of AFCs measured at
some points from first to third parity, we classified the cows into three tertiles: <11 (low), 11–15 (intermediate), and ≥ 15 (high). We then compared the reproductive performance of the
first through third parity cows among the groups. The hazards of pregnancy by 200 days postpartum were higher in the high group than in the other groups (P < 0.05). Our findings
demonstrate that between-lactation repeatability of AFC from first through third parity in dairy cows is very high, and that cows with an AFC of ≥ 15 have a better reproductive performance
than cows with a low AFC.
Collapse
Affiliation(s)
- Keisuke Koyama
- Dairy Research Center, Hokkaido Research Organization, Hokkaido 086-1135, Japan
| | - Takeshi Koyama
- Dairy Research Center, Hokkaido Research Organization, Hokkaido 086-1135, Japan
| | - Masahito Sugimoto
- Dairy Research Center, Hokkaido Research Organization, Hokkaido 086-1135, Japan
| |
Collapse
|
37
|
Zamami Y, Kouno Y, Niimura T, Chuma M, Imai T, Mitsui M, Koyama T, Kayano M, Okada N, Hamano H, Goda M, Imanishi M, Takechi K, Horinouchi Y, Kondo Y, Yanagawa H, Kitamura Y, Sendo T, Ujike Y, Ishizawa K. Relationship between the administration of nicardipine hydrochloride and the development of delirium in patients on mechanical ventilation. Pharmazie 2018; 73:740-743. [PMID: 30522561 DOI: 10.1691/ph.2018.8711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
A history of hypertension is a known risk factor for delirium in patients in intensive care units, but the effect of antihypertensive agents on delirium development is unclear. Nicardipine, a calcium channel blocker, is widely used in ICU as a treatment agent for hypertensive emergency. This study investigated the relationship between the administration of nicardipine hydrochloride and delirium development in patients under mechanical ventilation. We conducted a medical chart review of 103 patients, who were divided into two groups according to the use of nicardipine hydrochloride. The prevalence of delirium was compared with respect to factors such as age, sex, laboratory data, and medical history, by multivariate analysis. 21 patients (20.4 %) were treated with nicardipine hydrochloride in 103 patients. The treatment and non-treatment groups differed significantly in age (72 vs. 65 years) and history of high blood pressure (57% vs. 11%). Multivariate analysis revealed that patients in the treatment group developed delirium significantly less often than those in the non-treatment group (19% vs. 48%). These results suggested that treatment of high blood pressure with nicardipine hydrochloride is a possible method for preventing the development of delirium.
Collapse
|
38
|
Kitano S, Shimizu T, Koyama T, Ebata T, Iwasa S, Kondo S, Shimomura A, Fujiwara Y, Yamamoto N, Baum C, Li S, Rietschel P, Sims T. A phase I trial of the safety and pharmacokinetics of cemiplimab, a human monoclonal antibody to programmed death-1, in Japanese patients with advanced malignancies, including expansion cohorts for patients with non-small-cell lung cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy430.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
39
|
Yamamoto N, Fujiwara Y, Kondo S, Iwasa S, Yonemori K, Shimomura A, Kitano S, Shimizu T, Koyama T, Ebata T, Sato N, Nakai K, Inatani M, Tamura K. Phase I study of IDO1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with atezolizumab in Japanese patients with advanced solid tumors. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy279.411] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Harada K, Sugie M, Takahashi T, Nara M, Koyama T, Fujimoto H, Kyo S, Ito H. P4188Cognitive impairment in the elderly people with preserved ejection fraction is related to the reduced peak exercise stroke volume. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- K Harada
- Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
| | - M Sugie
- Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
| | - T Takahashi
- Tokyo University of Technology, Tokyo, Japan
| | - M Nara
- Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
| | - T Koyama
- Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
| | - H Fujimoto
- Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
| | - S Kyo
- Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
| | - H Ito
- Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
| |
Collapse
|
41
|
Koyama T, Omori R, Koyama K, Matsui Y, Sugimoto M. Optimization of diagnostic methods and criteria of endometritis for various postpartum days to evaluate infertility in dairy cows. Theriogenology 2018; 119:225-232. [PMID: 30055393 DOI: 10.1016/j.theriogenology.2018.07.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Revised: 07/03/2018] [Accepted: 07/05/2018] [Indexed: 11/28/2022]
Abstract
Postpartum endometritis is the main cause of infertility in dairy cows, but there is a lack of critical diagnostic criteria. We aimed to 1) determine the optimal diagnostic method and criteria of endometritis for various postpartum days to evaluate infertility, and 2) assess the diagnostic accuracy of a combination of diagnostic methods. Holstein dairy cows (n = 441) from nine commercial dairy herds were examined at 42 ± 7 days postpartum by using 5 methods: 1) transrectal palpation measurement of the cervical diameter, 2) ultrasonographic measurement of the fluid in uterus (FIU) score, 3) vaginoscopic detection of external uterine orifice hyperemia, 4) vaginal discharge score (VDS), and 5) endometrial cytological percentage of polymorphonuclear leukocytes (PMN%). The clinical findings that were significant in the Pearson chisquare test and had the highest sum of sensitivity and specificity for infertility at 100, 125, 150, 175, and 200 days after parturition were determined the optimal criteria of endometritis. Logistic regression and the Cox proportional hazards model were used to compare the accuracies of the different diagnostic methods for infertility at various postpartum days. The combinations of methods which were significant in Pearson chisquare test and had the highest sum of sensitivity and specificity for infertility were proposed as the optimal combination for determination of endometritis status for various postpartum day. The optimal diagnostic criteria were PMN% ≥ 6.0, FIU ≥ 2 (continuous hyperechogenic or large amount of storage material), or VDS ≥ 2 (mucopurulent or worse vaginal discharge) for postpartum days 100 and 125; PMN% ≥ 8.0, FIU = 3 (large amount of storage material), VDS ≥ 2, or external uterine orifice hyperemia for day 150; PMN% ≥ 6.0, FIU = 3, VDS ≥ 2, or external uterine orifice hyperemia for day 175; and PMN% ≥ 5.0, FIU = 3, VDS ≥ 2, or external uterine orifice hyperemia for day 200. Only the results of endometrial cytology were related to infertility regardless of the postpartum days to evaluate infertility or statistical models. Compared with the sensitivity and specificity of a single diagnostic method, the sensitivity of a combination of methods improved but specificity decreased. We concluded that different diagnostic methods and criteria were required for postpartum days to evaluate infertility and diagnostic accuracy was improved by a combination of diagnostic methods rather than by a single method.
Collapse
Affiliation(s)
- Takeshi Koyama
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, 086-1153, Japan.
| | - Ryosuke Omori
- Division of Bioinformatics, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, 001-0020, Japan
| | - Keisuke Koyama
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, 086-1153, Japan
| | - Yoshitaka Matsui
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, 086-1153, Japan
| | - Masahito Sugimoto
- Hokkaido Research Organization, Dairy Research Center, Nakashibetsu, Hokkaido, 086-1153, Japan
| |
Collapse
|
42
|
Nagasawa Y, Koyama T, Okada S. Energetics and electronic structures of perylene confined in carbon nanotubes. R Soc Open Sci 2018; 5:180359. [PMID: 30110483 PMCID: PMC6030348 DOI: 10.1098/rsos.180359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/07/2018] [Accepted: 05/25/2018] [Indexed: 06/08/2023]
Abstract
The energetics and geometries of perylene encapsulated in carbon nanotubes (CNTs) have been investigated employing density functional theory using the generalized gradient approximation combined with the van der Waals correction. Our calculations show that the encapsulated perylene molecules possess two metastable molecular conformations with respect to the CNT wall, which are almost degenerate with each other. A standing conformation, with respect to the CNT wall, is the ground state conformation for a semiconducting (19,0)CNT, while a lying conformation is the ground state for a metallic (11,11)CNT. Cooperation and competition between perylene-perylene and perylene-CNT interactions cause these possible perylene conformations inside CNTs. However, the electronic structure of the CNT encapsulating the perylene molecules is found to be insensitive to the molecular conformation.
Collapse
Affiliation(s)
- Yuya Nagasawa
- Graduate School of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8571, Japan
| | - Takeshi Koyama
- Department of Applied Physics, Nagoya University, Chikusa, Nagoya 464-8603, Japan
| | - Susumu Okada
- Graduate School of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8571, Japan
| |
Collapse
|
43
|
Yamamoto S, Omi T, Akai H, Kubota Y, Takahashi Y, Suzuki Y, Hirata Y, Yamamoto K, Yukawa R, Horiba K, Yumoto H, Koyama T, Ohashi H, Owada S, Tono K, Yabashi M, Shigemasa E, Yamamoto S, Kotsugi M, Wadati H, Kumigashira H, Arima T, Shin S, Matsuda I. Element Selectivity in Second-Harmonic Generation of GaFeO_{3} by a Soft-X-Ray Free-Electron Laser. Phys Rev Lett 2018; 120:223902. [PMID: 29906133 DOI: 10.1103/physrevlett.120.223902] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/21/2017] [Indexed: 05/27/2023]
Abstract
Nonlinear optical frequency conversion has been challenged to move down to the extreme ultraviolet and x-ray region. However, the extremely low signals have allowed researchers to only perform transmission experiments of the gas phase or ultrathin films. Here, we report second harmonic generation (SHG) of the reflected beam of a soft x-ray free-electron laser from a solid, which is enhanced by the resonant effect. The observation revealed that the double resonance condition can be met by absorption edges for transition metal oxides in the soft x-ray range, and this suggests that the resonant SHG technique can be applicable to a wide range of materials. We discuss the possibility of element-selective SHG spectroscopy measurements in the soft x-ray range.
Collapse
Affiliation(s)
- Sh Yamamoto
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - T Omi
- Department of Advanced Materials Science, The University of Tokyo, Kashiwa 277-8561, Japan
| | - H Akai
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - Y Kubota
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - Y Takahashi
- Tokyo University of Science, Katsushika 125-8585, Japan
| | - Y Suzuki
- Tokyo University of Science, Katsushika 125-8585, Japan
| | - Y Hirata
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - K Yamamoto
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - R Yukawa
- Photon Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), 1-1 Oho, Tsukuba 305-0801, Japan
| | - K Horiba
- Photon Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), 1-1 Oho, Tsukuba 305-0801, Japan
| | - H Yumoto
- Japan Synchrotron Radiation Research Institute, Sayo, Hyogo 679-5198, Japan
| | - T Koyama
- Japan Synchrotron Radiation Research Institute, Sayo, Hyogo 679-5198, Japan
| | - H Ohashi
- Japan Synchrotron Radiation Research Institute, Sayo, Hyogo 679-5198, Japan
| | - S Owada
- RIKEN SPring-8 Center, Sayo, Hyogo 679-5148, Japan
| | - K Tono
- Japan Synchrotron Radiation Research Institute, Sayo, Hyogo 679-5198, Japan
| | - M Yabashi
- RIKEN SPring-8 Center, Sayo, Hyogo 679-5148, Japan
| | - E Shigemasa
- UVSOR Facility, Institute for Molecular Science, Okazaki 444-8585, Japan
- Sokendai (the Graduate University for Advanced Studies), Okazaki 444- 8585, Japan
| | - S Yamamoto
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - M Kotsugi
- Tokyo University of Science, Katsushika 125-8585, Japan
| | - H Wadati
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - H Kumigashira
- Photon Factory, Institute of Materials Structure Science, High Energy Accelerator Research Organization (KEK), 1-1 Oho, Tsukuba 305-0801, Japan
| | - T Arima
- Department of Advanced Materials Science, The University of Tokyo, Kashiwa 277-8561, Japan
- RIKEN Center for Emergent Matter Science (CEMS), Wako 351-0198, Japan
| | - S Shin
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| | - I Matsuda
- Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan
| |
Collapse
|
44
|
Yamada KT, Suzuki M, Pradipto AM, Koyama T, Kim S, Kim KJ, Ono S, Taniguchi T, Mizuno H, Ando F, Oda K, Kakizakai H, Moriyama T, Nakamura K, Chiba D, Ono T. Microscopic Investigation into the Electric Field Effect on Proximity-Induced Magnetism in Pt. Phys Rev Lett 2018; 120:157203. [PMID: 29756866 DOI: 10.1103/physrevlett.120.157203] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2017] [Indexed: 06/08/2023]
Abstract
Electric field effects on magnetism in metals have attracted widespread attention, but the microscopic mechanism is still controversial. We experimentally show the relevancy between the electric field effect on magnetism and on the electronic structure in Pt in a ferromagnetic state using element-specific measurements: x-ray magnetic circular dichroism (XMCD) and x-ray absorption spectroscopy (XAS). Electric fields are applied to the surface of ultrathin metallic Pt, in which a magnetic moment is induced by the ferromagnetic proximity effect resulting from a Co underlayer. XMCD and XAS measurements performed under the application of electric fields reveal that both the spin and orbital magnetic moments of Pt atoms are electrically modulated, which can be explained not only by the electric-field-induced shift of the Fermi level but also by the change in the orbital hybridizations.
Collapse
Affiliation(s)
- K T Yamada
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - M Suzuki
- Japan Synchrotron Radiation Research Institute, Sayo, Hyogo 679-5198, Japan
| | - A-M Pradipto
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
- Department of Physics Engineering, Mie University, Tsu, Mie 514-8507, Japan
| | - T Koyama
- Department of Applied Physics, The University of Tokyo, Bunkyo, Tokyo 113-8656, Japan
| | - S Kim
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - K-J Kim
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - S Ono
- Central Research Institute of Electric Power Industry, Yokosuka, Kanagawa 240-0196, Japan
| | - T Taniguchi
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - H Mizuno
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - F Ando
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - K Oda
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - H Kakizakai
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - T Moriyama
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
| | - K Nakamura
- Department of Physics Engineering, Mie University, Tsu, Mie 514-8507, Japan
| | - D Chiba
- Department of Applied Physics, The University of Tokyo, Bunkyo, Tokyo 113-8656, Japan
| | - T Ono
- Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan
- Center for Spintronics Research Network (CSRN), Graduate School of Engineering Science, Osaka University, Toyonaka, Osaka 560-8531, Japan
| |
Collapse
|
45
|
Koyama T, Kondo S, Shimizu T, Fujiwara Y, Kitano S, Ebata T, Shimomura A, Morizane C, Okusaka T, Yamamoto N. Impact of chronic hepatitis virus infection on the feasibility and efficacy for Asian patients with hepatocellular carcinoma in phase I clinical trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
46
|
Shimomura A, Ebata T, Koyama T, Iwasa S, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Shimizu T, Yamamoto N. Comparison of model-based dose escalation design with rule-based design of phase I oncology trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Ebata T, Shimomura A, Koyama T, Iwasa S, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Shimizu T, Yamamoto N. Impact by age on dose-limiting toxicities in phase 1 oncology trials of cytotoxic agents and molecular targeted agents. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
48
|
Tobushi T, Ando SI, Takagawa J, Kumagai N, Kadokami T, Dohi K, Joho S, Wada O, Koyama T, Haruki N, Asanoi H, Momomura SI. Is the respiratory stability during sleep in patients with severe heart failure influenced by the nocturnal oxygen level? A sub-analysis of the prost study using a novel respiratory stability index. Sleep Med 2017. [DOI: 10.1016/j.sleep.2017.11.964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
49
|
Ebata T, Shimizu T, Iizumi S, Koyama T, Shimomura A, Iwasa S, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Yamamoto N. Prognostic factors of patients received immunocheckpoint inhibitors in oncology phase 1 trials. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx658.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
50
|
Kuriyama N, Ihara M, Koyama T, Mizuno T, Ozaki E, Kondo M, Tokuda T, Tamura A, Kazuo T, Nakagawa M, Watanabe Y. Vasoactive mid-regional pro-adrenomedullin is associated with cognitive decline accompa-nying deep white matter lesions in the brain: A longitudinal brain MRI study. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|